BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/23/2017 11:56:00 AM | Browse: 407 | Download: 450
Publication Name World Journal of Cardiology
Manuscript ID 31152
Country/Territory United States
2016-11-01 09:03
Peer-Review Started
2016-11-04 08:28
To Make the First Decision
2016-12-14 08:44
Return for Revision
2016-12-15 11:46
2016-12-26 16:55
Second Decision
2017-01-10 17:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-01-18 10:11
Articles in Press
2017-01-18 10:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-02-20 13:26
Publish the Manuscript Online
2017-02-23 11:56
ISSN 1949-8462 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Meta-Analysis
Article Title Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis
Manuscript Source Invited Manuscript
All Author List Mahesh Anantha Narayanan, Yogesh NV Reddy, Janani Baskaran, Abhishek Deshmukh, David G Benditt and Ganesh Raveendran
Funding Agency and Grant Number
Corresponding author Mahesh Anantha Narayanan, MD, Division of Cardiovascular Diseases, University of Minnesota Medical Center, 500 SE Harvard Street, Minneapolis, MN 55455, United States. manantha@umn.edu
Keywords Ivabradine; Heart failure
Core Tip Ivabradine was recently given a class IIa indication in the 2016 focused update on systolic heart failure in the ACC/AHA/HFSA guidelines. But it is unclear whether ivabradine offers any additional benefit over and above that offered by beta blockers. Our analysis showed lower heart rate and combined end point of cardiac death and heart failure hospitalization at follow-up with ivabradine combined with beta blocker compared to beta blocker alone. Combined therapy did not improve cardiovascular mortality, all cause mortality or heart failure hospitalization. Further studies are essential before widespread use of combination therapy with ivabradine can be recommended.
Publish Date 2017-02-23 11:56
Citation Anantha Narayanan M, Reddy YNV, Baskaran J, Deshmukh A, Benditt DG, Raveendran G. Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis. World J Cardiol 2017; 9(2): 182-190
Url http://www.wjgnet.com/1949-8462/full/v9/i2/182.htm
DOI http://dx.doi.org/10.4330/wjc.v9.i2.182
Full Article (PDF) WJC-9-182.pdf
Full Article (Word) WJC-9-182.doc
Manuscript File 31152-Review.docx
Answering Reviewers 31152-Answering reviewers.pdf
Audio Core Tip 31152-Audio core tip.wav
Biostatistics Review Certificate 31152-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 31152-Conflict-of-interest statement.pdf
Copyright License Agreement 31152-Copyright assignment.pdf
Data Sharing Statement 31152-Data sharing statement.pdf
Supplementary Material 31152-Supplementary material.docx
Peer-review Report 31152-Peer-review(s).pdf
Scientific Misconduct Check 31152-Scientific misconduct check.pdf
Scientific Editor Work List 31152-Scientific editor work list.pdf